Disease |
Protein |
BMRB entry |
Androgen insensitivity syndrome |
Lipocalin-type prostaglandin D synthase/U-46619 complex |
18473 |
Autoimmune Polyendocrinopathy-cadidiasis-ectodermal dystrophy |
AIRE PHD Finger |
16878
18374
6374 |
|
Hippocalcin |
18627 |
Cystic Fibrosis |
Cystic fibrosis transmembrane conductance regulator p25 |
4595
4598 |
|
Cystic fibrosis transmembrane conductance regulator p26 |
4596
4597 |
|
Cystic fibrosis transmembrane conductance regulator NBD1 |
16367
16393
16394
|
|
Cystic fibrosis transmembrane regulator - PDZ domain of CAL |
18205 |
Diabetes |
A-chain peptide |
20052 |
|
AbaA3-DKP-insulin |
15455 |
|
Allo-ThrA3 DKP-insulin |
15454 |
|
Amylin Nucleation Site |
5302 |
|
Dynamic Alpha-Helix Structure of Human Amylin |
16104
16105 |
|
Glucose-dependent insulinotropic polypeptide |
17330
17331 |
|
Insulin A chain |
556
25260 |
|
Insulin B chain |
557
25260 |
|
Insulin Mutant A22Gly-B31Arg |
17803 |
|
Insulin Mutant A22Gly-B31Lys-B31Arg |
16915 |
|
Insulin Mutant B22Gln |
25261 |
|
Insulin Mutant B31Lys-B31Arg |
11016 |
|
Insulin mutant GLU-B21-D-GLU HIS-B10 ASP PRO-B28-LYS LYS-B29-PRO |
16343 |
|
Insulin Mutant GLY-B20-D-ALA GLY-B23-2 PRO-B28-LYS LYS-B29-PRO |
17107 |
|
Insulin mutant GLY-B8-D-ALA HIS-B10-2 ASP PRO-B28-LYS LYS-B29-PRO |
16663 |
|
Insulin mutant ILE-A2-LEU VAL-A3-LEU-2 HIS-B10-ASP PRO-B28-LYS LYS-B29-PRO |
17108 |
|
Insulin-like growth factor binding protein-2 |
17743 |
|
PED/PEA-15 death effector domain |
18412 |
|
Proinsulin |
16608 |
|
Protein islet amyloid polypeptide |
7311 |
|
ThrA3-DKP-insulin |
15450 |
|
Unfolded Insulin A chain |
16026
16027 |
Familial Hypercholesterolaemia |
Human fibrillin-1 |
17334 |
Shwachman-Bodian-Diamond Syndrome |
SBDS Protein |
16119
17479 |